Form 4: USANA CPO Paul Jones Granted 25,622 Restricted Stock Units

USANA Health Sciences' Chief People Officer, Paul A. Jones, was granted 25,622 restricted stock units, which will vest over four years.

Summary

• Paul A. Jones, Chief People Officer of USANA Health Sciences Inc. (USNA), was granted 25,622 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of USNA common stock.
• The grant occurred on February 19, 2026.
• The RSUs will vest at 25% on each subsequent February 19th, implying a four-year vesting schedule.
• Following this transaction, Paul A. Jones beneficially owns a total of 51,207 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this RSU grant as a moderately positive event, reflecting standard executive compensation practices aimed at aligning management incentives with long-term shareholder value, without indicating any immediate operational or financial shifts.

Positives

• The grant of Restricted Stock Units (RSUs) aligns the Chief People Officer's long-term interests with those of shareholders, incentivizing performance and retention.
• The vesting schedule over four years promotes sustained commitment to the company's long-term success.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates a future increase in Paul A. Jones's direct ownership of USANA common stock as the units convert over the next four years, contingent on continued employment.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units is a standard practice in executive compensation across various industries, particularly in the health and wellness sector, to attract, retain, and motivate key leadership by linking their long-term incentives to company performance and shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a common practice, comparable to compensation structures at companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS), which frequently utilize equity awards to align executive interests with long-term shareholder value.
• A four-year vesting schedule, with annual tranches, is typical for such grants, providing a balance between immediate incentive and long-term retention, similar to practices observed in many publicly traded companies across various sectors.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon RSU conversion, but also increased alignment of executive interests with long-term shareholder value.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives for key personnel.

Next Steps

• The Restricted Stock Units will vest at 25% annually on February 19th, starting in 2027.
• Upon vesting, the RSUs will convert into shares of USANA common stock, increasing Paul A. Jones's direct beneficial ownership.

Key Dates

Keywords

USANA Health Sciences, USNA, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Paul A. Jones, Chief People Officer, Form 4